ReviewGlobalization and health2024
Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia.
Review in Globalization and health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Exploring the availability and content of vaccinology courses across the globe: A scoping review.Human vaccines & immunotherapeutics · 2026Article
- The Relationship Between COVID-19 Vaccine Regret, Distrust of the Healthcare System, and Future Vaccine Intentions.Journal of evaluation in clinical practice · 2026Article
- Community-based intervention to reach the last mile of childhood vaccination coverage in Burera district, Rwanda: a mixed method study.BMC public health · 2026Article
- Life Course Vaccination Continuum (LCVAC): An Expert Consensus on Life Course Vaccination in India.Cureus · 2026Review
- Prevalence and factors associated with vaccine hesitancy among caregivers of children under five years in Pece-Laroo Division, Gulu City, Uganda.Tropical medicine and health · 2026Article
- Impact of Vaccines Across the Lifespan: A New Perspective in Public Health-Conclusions of an Expert Panel-Part 1.Vaccines · 2026Review
- Health Equity Barriers to Accessing Vaccination and Screening Services in Low- and Middle-Income Countries: A Narrative Review.Risk management and healthcare policy · 2026Review
- Recent Advances in Strategies Against Measles Spread: Clinical and Epidemiological Aspects, Impact, Vaccine Innovations, and Sustainable Recommendations.TheScientificWorldJournal · 2026Review
- Community engagement for vaccine delivery in low- and middle-income countries and humanitarian settings: A scoping umbrella review.PLOS global public health · 2026Article
- Correlates of reported rotavirus vaccination among young Indonesian children: a cross-sectional analysis of the Indonesia Family Life Survey (IFLS-5).Frontiers in public health · 2026Article
- Article
- Psychosocial and digital predictors of Hepatitis B vaccination uptake in healthcare workers: insights from a Nigerian tertiary hospital.Tropical medicine and health · 2025Article
- Overcoming barriers to medical countermeasures: Strengthening global biosecurity.Human vaccines & immunotherapeutics · 2025Review
- Article
- The behavioral and social drivers of HPV vaccination among parents and young people in Indonesia: a scoping review.Cancer causes & control : CCC · 2025Article
- Epidemiological investigation of a cholera outbreak and its socioeconomic determinants in southwest state, Somalia, January - August, 2024.Conflict and health · 2025Article
- Aging in Southeast Asia and Japan: Challenges and opportunities.Geriatrics & gerontology international · 2025Review
- Epidemiological trends and clinical characteristics of measles in Iraq (2023-2024): a retrospective cross-sectional study.BMC infectious diseases · 2025Article
- Routine malaria vaccination in Africa: a step toward malaria eradication?Malaria journal · 2025Review
- Vaccine Hesitancy and Immunization Patterns in Central and Eastern Europe: Sociocultural, Economic, Political, and Digital Influences Across Seven Countries.Risk management and healthcare policy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIndonesia has made progress in increasing vaccine coverage, but equitable access remains challenging, especially in remote areas. Despite including vaccines in the National Immunization Program (NIP), coverage has not met WHO and UNICEF targets, with childhood immunization decreasing during the COVID-19 pandemic. COVID-19 vaccination has also experienced hesitancy, slowing efforts to end the pandemic. SCOPE: This article addresses the issue of vaccine hesitancy and its impact on vaccination initiatives amidst the COVID-19 pandemic. This article utilizes the vaccine hesitancy framework to analyze previous outbreaks of vaccine-preventable diseases and their underlying causes, ultimately providing recommendations for addressing the current situation. The analysis considers the differences between the pre-pandemic circumstances and the present and considers the implementation of basic and advanced strategies. KEY FINDINGS AND
conclusionVaccine hesitancy is a significant challenge in the COVID-19 pandemic, and public health campaigns and community engagement efforts are needed to promote vaccine acceptance and uptake. Efforts to address vaccine hesitancy promote trust in healthcare systems and increase the likelihood of individuals seeking preventive health services. Vaccine hesitancy requires a comprehensive, culturally sensitive approach that considers local contexts and realities. Strategies should be tailored to specific cultural and societal contexts and monitored and evaluated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.